These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 3095312

  • 21. Results of a brief survey on the prescribing practices for monoamine oxidase inhibitor antidepressants.
    Clary C, Mandos LA, Schweizer E.
    J Clin Psychiatry; 1990 Jun; 51(6):226-31. PubMed ID: 2347859
    [Abstract] [Full Text] [Related]

  • 22. A possible L-deprenyl induced hypertensive reaction.
    McGrath PJ, Stewart JW, Quitkin FM.
    J Clin Psychopharmacol; 1989 Aug; 9(4):310-1. PubMed ID: 2504782
    [No Abstract] [Full Text] [Related]

  • 23. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL, Sunderland T, Cohen RM.
    Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
    [Abstract] [Full Text] [Related]

  • 24. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP, Boyer WF, Tyler DL, Neborsky RJ.
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [Abstract] [Full Text] [Related]

  • 25. Transdermal selegiline: a novel MAOI formulation for depression.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2006 Jul; 44(7):9-12. PubMed ID: 17310829
    [No Abstract] [Full Text] [Related]

  • 26. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs.
    Blackwell B, Marley E, Price J, Taylor D.
    Br J Psychiatry; 1967 Apr; 113(497):349-65. PubMed ID: 6034391
    [No Abstract] [Full Text] [Related]

  • 27. The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability.
    Robinson DS, Amsterdam JD.
    J Affect Disord; 2008 Jan; 105(1-3):15-23. PubMed ID: 17568687
    [Abstract] [Full Text] [Related]

  • 28. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD, Bodkin JA.
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [Abstract] [Full Text] [Related]

  • 29. Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake.
    Salter M, Kenney A.
    Cardiovasc Toxicol; 2018 Dec; 18(6):583-586. PubMed ID: 30083815
    [Abstract] [Full Text] [Related]

  • 30. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
    Rabkin JG, Quitkin FM, McGrath P, Harrison W, Tricamo E.
    J Clin Psychopharmacol; 1985 Feb; 5(1):2-9. PubMed ID: 3973068
    [Abstract] [Full Text] [Related]

  • 31. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F, Bouvy PF, Touw DJ.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1937-40. PubMed ID: 14574773
    [Abstract] [Full Text] [Related]

  • 32. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul 04; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 33. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH, Cohen BM, Baldessarini RJ, Cole JO.
    Am J Psychiatry; 1988 Dec 04; 145(12):1552-6. PubMed ID: 3273886
    [Abstract] [Full Text] [Related]

  • 34. Paroxysmal hypertensive crises induced by selegiline in a patient with Parkinson's disease.
    Ito D, Amano T, Sato H, Fukuuchi Y.
    J Neurol; 2001 Jun 04; 248(6):533-4. PubMed ID: 11499649
    [No Abstract] [Full Text] [Related]

  • 35. Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
    Tariot PN, Sunderland T, Cohen RM, Newhouse PA, Mueller EA, Murphy DL.
    J Clin Psychopharmacol; 1988 Feb 04; 8(1):23-7. PubMed ID: 3127432
    [Abstract] [Full Text] [Related]

  • 36. MAOIs and Ménière's syndrome.
    Mattes JA.
    Am J Psychiatry; 1990 Apr 04; 147(4):534. PubMed ID: 2316744
    [No Abstract] [Full Text] [Related]

  • 37. Psychopharmacology of the anxiety disorders.
    Ballenger JC.
    Psychiatr Clin North Am; 1984 Dec 04; 7(4):757-71. PubMed ID: 6151647
    [Abstract] [Full Text] [Related]

  • 38. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC.
    Am J Psychiatry; 1985 Dec 04; 142(12):1487-8. PubMed ID: 4073318
    [Abstract] [Full Text] [Related]

  • 39. Autoinduction of hypertensive reactions by tranylcypromine?
    Keck PE, Pope HG, Nierenberg AA.
    J Clin Psychopharmacol; 1989 Feb 04; 9(1):48-51. PubMed ID: 2486182
    [Abstract] [Full Text] [Related]

  • 40. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
    Spiker DG, Pugh DD.
    Arch Gen Psychiatry; 1976 Jul 04; 33(7):828-30. PubMed ID: 942286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.